20 LATEST RESOURCES (11 INDEXED)
×
The Effectiveness and Cost-Effectiveness of Plant Sterol or Stanol-Enriched Functional Foods as a Primary Prevention Strategy for People with Cardiovascular Disease Risk in England: A Modeling Study · November 2017
Articles
European Journal of Health Economics
×
A Cost-Effectiveness Analysis of Lisdexamfetamine Dimesylate in the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder in the UK · January 2017
Articles
European Journal of Health Economics
×
Comparative Treatment Patterns, Healthcare Resource Utilization and Costs of Atomoxetine and Long-Acting Methylphenidate among Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in Germany · November 2016
Articles
European Journal of Health Economics
×
The Impact of Memantine in Combination with Acetylcholinesterase Inhibitors on Admission of Patients with Alzheimer’s Disease to Nursing Homes: Cost-Effectiveness Analysis in France · August 2013
Articles
European Journal of Health Economics
×
Cost-Effectiveness of Long-Acting Injectable Risperidone versus Flupentixol Decanoate in the Treatment of Schizophrenia: A Markov Model Parameterized Using Administrative Data · February 2013
Abstracts
European Journal of Health Economics
×
The Cost-Effectiveness of Smoking Cessation Support Delivered by Mobile Phone Text Messaging: Txt2stop · September 2012
Articles
European Journal of Health Economics
×
Cost-Effectiveness of Pregabalin versus Venlafaxine in the Treatment of Generalized Anxiety Disorder: Findings from a Spanish Perspective · June 2009
Articles
European Journal of Health Economics
×
Interactions between Cigarette and Alcohol Consumption in Rural China · May 2009
Articles
European Journal of Health Economics
×
A Decision Model to Compare Health Care Costs of Olanzapine and Risperidone Treatment of Schizophrenia in Germany (NHS Economic Evaluation Database) · September 2006
Abstracts
University of York>European Journal of Health Economics
×
Cost-Effectiveness of Venlafaxine XL Compared with Diazepam in the Treatment of Generalised Anxiety Disorder in the United Kingdom (NHS Economic Evaluation Database) · June 2005
Abstracts
University of York>European Journal of Health Economics
×
A Pharmacoeconomic Evaluation of Zuclopenthixol Compared with Haloperidol and Risperidone in the Treatment of Schizophrenia · January 2002
Abstracts
European Journal of Health Economics